Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Jakob Jóhannsson; Lena Specht; Johannes Mejer; Bjarne Anker Jensen

Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Jakob Jóhannsson, Lena Specht, Johannes Mejer, Bjarne Anker Jensen

51 Citationer (Scopus)

Abstract

Indolent non-Hodgkin's lymphoma (INHL) and chronic lymphocytic leukemia (CLL) are highly sensitive to radiotherapy (RT). Previous retrospective studies have shown high response rates after local palliative RT of 4 Gy in 2 fractions, which prompted this prospective Phase II trial of the palliative effect of this regimen in patients with disseminated INHL or CLL.

Originalsprog	Engelsk
Tidsskrift	International Journal of Radiation: Oncology - Biology - Physics
Vol/bind	54
Udgave nummer	5
Sider (fra-til)	1466-70
Antal sider	5
ISSN	0360-3016
Status	Udgivet - 1 dec. 2002

Citationsformater

Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia. / Jóhannsson, Jakob; Specht, Lena; Mejer, Johannes et al.
I: International Journal of Radiation: Oncology - Biology - Physics, Bind 54, Nr. 5, 01.12.2002, s. 1466-70.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{9d3384ee41524f53a32ef65d13059ce2,

title = "Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia",

abstract = "Indolent non-Hodgkin's lymphoma (INHL) and chronic lymphocytic leukemia (CLL) are highly sensitive to radiotherapy (RT). Previous retrospective studies have shown high response rates after local palliative RT of 4 Gy in 2 fractions, which prompted this prospective Phase II trial of the palliative effect of this regimen in patients with disseminated INHL or CLL.",

author = "Jakob J{\'o}hannsson and Lena Specht and Johannes Mejer and Jensen, {Bjarne Anker}",

year = "2002",

month = dec,

day = "1",

language = "English",

volume = "54",

pages = "1466--70",

journal = "International Journal of Radiation: Oncology - Biology - Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia

AU - Jóhannsson, Jakob

AU - Specht, Lena

AU - Mejer, Johannes

AU - Jensen, Bjarne Anker

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Indolent non-Hodgkin's lymphoma (INHL) and chronic lymphocytic leukemia (CLL) are highly sensitive to radiotherapy (RT). Previous retrospective studies have shown high response rates after local palliative RT of 4 Gy in 2 fractions, which prompted this prospective Phase II trial of the palliative effect of this regimen in patients with disseminated INHL or CLL.

AB - Indolent non-Hodgkin's lymphoma (INHL) and chronic lymphocytic leukemia (CLL) are highly sensitive to radiotherapy (RT). Previous retrospective studies have shown high response rates after local palliative RT of 4 Gy in 2 fractions, which prompted this prospective Phase II trial of the palliative effect of this regimen in patients with disseminated INHL or CLL.

M3 - Journal article

C2 - 12459371

SN - 0360-3016

VL - 54

SP - 1466

EP - 1470

JO - International Journal of Radiation: Oncology - Biology - Physics

JF - International Journal of Radiation: Oncology - Biology - Physics

IS - 5

ER -

Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia

Abstract

Fingeraftryk

Citationsformater